Bayer Intellectual Property GMBH et al v. Teva Pharmaceuticals USA, Inc. et al
| Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc. |
| Teva Pharmaceuticals USA, Inc. and Teva Pharmaceutical Industries Ltd. |
| 1:2018cv01926 |
| December 5, 2018 |
| US District Court for the District of Delaware |
| Richard G Andrews |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on December 21, 2018. A more recent docket listing may be available from PACER.
| Document Text |
|---|
SO ORDERED, re #8 STIPULATION TO EXTEND TIME to Respond to the Complaint to February 25, 2019 (*Reset Answer Deadlines: Teva Pharmaceutical Industries Ltd. answer due 2/25/2019; Teva Pharmaceuticals USA, Inc. answer due 2/25/2019). Signed by Judge Richard G. Andrews on 12/21/2018. (nms)
|
| Filing 8 STIPULATION TO EXTEND TIME to Respond to the Complaint to February 25, 2019 - filed by Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Keller, Karen) |
| Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Filing 7 SUMMONS Returned Executed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. Teva Pharmaceuticals USA, Inc. served on 12/6/2018, answer due 12/27/2018. (Blumenfeld, Jack) |
| Summons Issued with Magistrate Consent Notice attached as to Teva Pharmaceutical Industries Ltd. on 12/6/2018; Teva Pharmaceuticals USA, Inc. on 12/6/2018. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (lak) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (lak) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GMBH filed by Bayer AG, Bayer Intellectual Property GMBH. (lak) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (lak) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 10/24/2018. Date of Expiration of Patent: 2/17/2034.Thirty Month Stay Deadline: 4/24/2021. (lak) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Filing 1 COMPLAINT - filed against Teva Pharmaceutical Industries Ltd., Teva Pharmaceuticals USA, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2517821.) - filed by Bayer Intellectual Property GMBH, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet)(lak) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
